Prevalence and prognostic significance of pulmonary artery aneurysms in adults with congenital heart disease

被引:15
|
作者
Gallego, Pastora [1 ]
Jose Rodriguez-Puras, Maria [1 ]
Serrano Gotarredona, Pilar [2 ]
Valverde, Israel [3 ]
Manso, Begona [3 ]
Gonzalez-Calle, Antonio [1 ,4 ]
Adsuar, Alejandro [1 ,4 ]
Cubero, Jose M. [1 ,5 ]
Diaz de la Llera, Luis [1 ,5 ]
Ordonez, Antonio [4 ]
Hosseinpour, Amir-Reza [1 ,4 ]
机构
[1] Hosp Univ Virgen Rocio, Adult Congenital Heart Dis Unit, Seville, Spain
[2] Hosp Univ Virgen Rocio, Dept Radiol, Seville, Spain
[3] Hosp Univ Virgen Rocio, Dept Pediat Cardiol, Seville, Spain
[4] Hosp Univ Virgen Rocio, Dept Cardiovasc Surg, Seville, Spain
[5] Hosp Univ Virgen Rocio, Dept Cardiol, Seville, Spain
关键词
Pulmonary artery dilatation; Congenital heart disease; Pulmonary artery dissection; Pulmonary arterial hypertension; NATURAL-HISTORY; HYPERTENSION; DILATATION; DISSECTION; PRESSURE; DEATH; DILATION; VALVE;
D O I
10.1016/j.ijcard.2018.05.129
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Prevalence and prognostic significance of pulmonary artery (PA) dilatation in congenital heart disease (CHD) have never been studied systematically. Methods: Chest X-rays of 1192 consecutive adults with CHD were reviewed. Major diameter of the PA was determined by imaging techniques in those with PA dilatation. A value >29 mm was considered abnormal. Data on anatomy, hemodynamics, residual lesions and outcomes were retrospectively collected. Results: Overall prevalence of PA dilatation was 18%. A minority of patients (5.5%) reached 40 mm (aneurysm; PAA) and 1.8% exceeded 50 mm. The most common PAA underlying malformations were pulmonary stenosis (21%), and shunts (55%). Significantly larger diameters were observed in hypertensive shunts (40 mm; IQR 36.7-45 mm vs. 34 mm; IQR 32-36 mm) (p < 0.0001). However, the largest diameters were found in conotruncal anomalies. There was no significant correlation between PA dimensions and systolic pulmonary pressure (r=-0.196), trans-pulmonary gradient (r=-0.203), pulmonary regurgitation (PR) (r=0.071) ormagnitude of shunt (r=0.137) (p > 0.05 for all). Over follow-up, 1 sudden death (SD) occurred in one Eisenmenger patient. Complications included coronary (3), recurrent laryngeal nerve (1) and airway (1) compressions, progressive PR (1), and PA thrombosis (1). Coronary compression and SD were strongly associated (univariate analysis) with pulmonary hypertension (120 vs. 55mmHg; p=0.002) but notwith extreme PA dilatation (range: 40-65mm). Conclusions: PA dilatation in CHD is common but only a small percentage of patients have PAA. Clinical impact on outcomes is low. Complications occurred almost exclusively in patients with pulmonary hypertension whereas PA diameter alone was not associated with adverse outcomes. (c) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:120 / 125
页数:6
相关论文
共 50 条
  • [41] Pulmonary Manifestations of Congenital Heart Disease in Children
    Johnson, Brandy N.
    Fierro, Julie L.
    Panitch, Howard B.
    PEDIATRIC CLINICS OF NORTH AMERICA, 2021, 68 (01) : 25 - 40
  • [42] Variation and significance of serum microRNA-21 level in pediatric pulmonary artery hypertension associated with congenital heart disease
    Shen, Yanming
    Liao, Dongshan
    Shangguan, Wenlin
    Chen, Liangwan
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [43] Pulmonary hypertension associated with congenital heart disease
    Beghetti, M.
    REVUE DES MALADIES RESPIRATOIRES, 2006, 23 : S49 - S59
  • [44] Pulmonary Hypertension Associated with Congenital Heart Disease
    Venkatesh, Prashanth
    Rosenzweig, Erika B.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2024, 20 (03) : 261 - 271
  • [45] Comparison of Pulmonary Artery Pressure Measurement With Doppler Echocardiography or With Right Heart Catheterization in Patients With Congenital Heart Disease
    Yin, Dan
    Wang, Ying
    Zheng, Min
    Wei, Huijing
    Li, Mi
    Lv, Tiewei
    Bai, Yonghong
    Tian, Jie
    Wu, Xiaoyun
    FRONTIERS IN PEDIATRICS, 2019, 7
  • [46] Pulmonary hypertension in adults with congenital heart disease. Clinical phenotypes and outcomes in the advanced pulmonary vasodilator era
    Wals-Rodriguez, Amadeo-Jose
    Rodriguez-Puras, Maria-Jose
    Garcia-Orta, Rocio
    Robledo, Juan
    Moreno, Eduardo
    Federero, Carmen
    Camacho, Rocio
    Manso, Begona
    Hernandez, Nuria
    Cubero, Jose Maria
    Abia, Raquel Ladron
    Ramos, Pilar Cejudo
    Ordonez, Antonio
    Gallego, Pastora
    HEART & LUNG, 2022, 51 : 75 - 81
  • [47] Heart Failure Risk Predictions and Prognostic Factors in Adults With Congenital Heart Diseases
    Leczycki, Patryk
    Banach, Maciej
    Maciejewski, Marek
    Bielecka-Dabrowa, Agata
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [48] Congenital heart disease in adults
    Findlow, D
    Doyle, E
    BRITISH JOURNAL OF ANAESTHESIA, 1997, 78 (04) : 416 - 430
  • [49] Pharmacological management of heart failure in adults with congenital heart disease
    Karnkowska, Barbara
    Harmouch, Wissam
    Newman, Peter
    Malik, Hamza
    Khwaja, Bisma
    Lewis, Alexandra
    Faluk, Mohammed
    Chatila, Khaled
    HEART FAILURE REVIEWS, 2024, 29 (06) : 1175 - 1185
  • [50] Prognostic implications of weight gain and weight loss in adults with congenital heart disease
    Egbe, Alexander C.
    Miranda, William R.
    Anderson, Jason H.
    Connolly, Heidi M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 371 : 147 - 152